These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 31425780

  • 1. Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis.
    Nakagawa H, Nemoto O, Igarashi A, Saeki H, Oda M, Kabashima K, Nagata T.
    J Allergy Clin Immunol; 2019 Dec; 144(6):1575-1583. PubMed ID: 31425780
    [Abstract] [Full Text] [Related]

  • 2. Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.
    Nakagawa H, Nemoto O, Igarashi A, Saeki H, Kaino H, Nagata T.
    J Am Acad Dermatol; 2020 Apr; 82(4):823-831. PubMed ID: 32029304
    [Abstract] [Full Text] [Related]

  • 3. Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study.
    Nakagawa H, Nemoto O, Igarashi A, Saeki H, Kabashima K, Oda M, Nagata T.
    J Am Acad Dermatol; 2021 Oct; 85(4):854-862. PubMed ID: 34118298
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis.
    Nakagawa H, Nemoto O, Igarashi A, Saeki H, Murata R, Kaino H, Nagata T.
    J Dermatol; 2020 Feb; 47(2):114-120. PubMed ID: 31820485
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study.
    Nakagawa H, Nemoto O, Igarashi A, Nagata T.
    Br J Dermatol; 2018 Feb; 178(2):424-432. PubMed ID: 28960254
    [Abstract] [Full Text] [Related]

  • 6. Post-hoc safety/efficacy analyses from pediatric delgocitinib atopic dermatitis trials.
    Fukuie T, Toyama H, Tanaka M, Ohashi-Doi K, Kabashima K.
    Pediatr Int; 2024 Feb; 66(1):e15798. PubMed ID: 39373522
    [Abstract] [Full Text] [Related]

  • 7. Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis: A phase 3, open-label, and long-term study.
    Nakagawa H, Igarashi A, Saeki H, Kabashima K, Tamaki T, Kaino H, Miwa Y.
    Allergol Int; 2024 Jan; 73(1):137-142. PubMed ID: 37100717
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged ≥2 years with mild-to-moderate atopic dermatitis.
    Ma L, Zhang L, Kobayashi M, Tao X, Qian Q, Cheng H, Liu S, Zhou Y, Chen Y, Zhang J.
    J Dermatol; 2023 Jul; 50(7):847-855. PubMed ID: 37154471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years.
    Luger TA, Hebert AA, Zaenglein AL, Silverberg JI, Tan H, Ports WC, Zielinski MA.
    Paediatr Drugs; 2022 Mar; 24(2):175-183. PubMed ID: 35292919
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R.
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial.
    Lin YK, Chang SH, Yang CY, See LC, Lee BH, Shih IH.
    J Ethnopharmacol; 2020 Mar 25; 250():112477. PubMed ID: 31838180
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.